Cargando…

Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism

BACKGROUND: Active renin mass concentration (ARC) is independent of the endogenous level of angiotensinogen, and less variable and more reproducible than plasma renin activity. Reference values for the aldosterone-to-renin ratio (ARR) using ARC are still undefined. The objective of the present study...

Descripción completa

Detalles Bibliográficos
Autores principales: Corbin, François, Douville, Pierre, Lebel, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165909/
https://www.ncbi.nlm.nih.gov/pubmed/21912488
http://dx.doi.org/10.2147/IJNRD.S22245
_version_ 1782211098109280256
author Corbin, François
Douville, Pierre
Lebel, Marcel
author_facet Corbin, François
Douville, Pierre
Lebel, Marcel
author_sort Corbin, François
collection PubMed
description BACKGROUND: Active renin mass concentration (ARC) is independent of the endogenous level of angiotensinogen, and less variable and more reproducible than plasma renin activity. Reference values for the aldosterone-to-renin ratio (ARR) using ARC are still undefined. The objective of the present study was to determine the threshold of ARR using ARC measurement to screen for primary aldosteronism. METHODS: A total of 211 subjects were included in the study, comprising 78 healthy normotensive controls, 95 patients with essential hypertension, and 38 patients with confirmed primary aldosteronism (20 with surgery-confirmed aldosterone-producing adenoma and 18 with idiopathic adrenal hyperplasia). Blood samples were drawn from ambulatory patients and volunteers in the mid-morning without specific dietary restriction for measuring plasma aldosterone concentration, ARC, and serum potassium. RESULTS: Most normotensive controls and essential hypertension patients had ARR results below 100 pmol/ng, a value which corresponded to 3.3 times the median of these two groups. CONCLUSION: Patients with ARR values above this level should be considered for further investigation (confirmatory tests) or for repeat testing should ARR values be borderline. This study indicates that ARC can be used reliably in determining ARR for primary aldosteronism screening.
format Online
Article
Text
id pubmed-3165909
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-31659092011-09-12 Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism Corbin, François Douville, Pierre Lebel, Marcel Int J Nephrol Renovasc Dis Original Research BACKGROUND: Active renin mass concentration (ARC) is independent of the endogenous level of angiotensinogen, and less variable and more reproducible than plasma renin activity. Reference values for the aldosterone-to-renin ratio (ARR) using ARC are still undefined. The objective of the present study was to determine the threshold of ARR using ARC measurement to screen for primary aldosteronism. METHODS: A total of 211 subjects were included in the study, comprising 78 healthy normotensive controls, 95 patients with essential hypertension, and 38 patients with confirmed primary aldosteronism (20 with surgery-confirmed aldosterone-producing adenoma and 18 with idiopathic adrenal hyperplasia). Blood samples were drawn from ambulatory patients and volunteers in the mid-morning without specific dietary restriction for measuring plasma aldosterone concentration, ARC, and serum potassium. RESULTS: Most normotensive controls and essential hypertension patients had ARR results below 100 pmol/ng, a value which corresponded to 3.3 times the median of these two groups. CONCLUSION: Patients with ARR values above this level should be considered for further investigation (confirmatory tests) or for repeat testing should ARR values be borderline. This study indicates that ARC can be used reliably in determining ARR for primary aldosteronism screening. Dove Medical Press 2011-07-28 /pmc/articles/PMC3165909/ /pubmed/21912488 http://dx.doi.org/10.2147/IJNRD.S22245 Text en © 2011 Corbin et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Corbin, François
Douville, Pierre
Lebel, Marcel
Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism
title Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism
title_full Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism
title_fullStr Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism
title_full_unstemmed Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism
title_short Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism
title_sort active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165909/
https://www.ncbi.nlm.nih.gov/pubmed/21912488
http://dx.doi.org/10.2147/IJNRD.S22245
work_keys_str_mv AT corbinfrancois activereninmassconcentrationtodeterminealdosteronetoreninratioinscreeningforprimaryaldosteronism
AT douvillepierre activereninmassconcentrationtodeterminealdosteronetoreninratioinscreeningforprimaryaldosteronism
AT lebelmarcel activereninmassconcentrationtodeterminealdosteronetoreninratioinscreeningforprimaryaldosteronism